Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Obstet Gynaecol ; 42(8): 3435-3440, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-37017372

RESUMEN

Twenty-five percent of cases of endometrial cancer appear in women with unfulfilled reproductive desires. An adequate selection of patients and a close hysteroscopic follow-up to monitor the endometrial response to the levonorgestrel-releasing intrauterine system (LNG-IUS) may be a valid and safe option for these patients. This is a case series and review of the literature study. We included eight patients diagnosed of complex endometrial hyperplasia with atypia (CEHA) or stage 1AG1 well-differentiated endometrial cancer without myometrial invasion who desired to get pregnant and opted for a conservative treatment. Follow-up was performed with hysteroscopy and directed biopsy at 3, 6 and 12 months. Of the 854 cases of complex endometrial hyperplasia with atypia (CEHA)/endometrial cancer were diagnosed, 2.3% were candidates for conservative management. We obtained a favourable regression of 71.2% at 6 months and 57% at one year with hormonal treatment. Conservative treatment in complex endometrial hyperplasia with atypia (CEHA)/low-grade endometrial cancer in reproductive age patients with a strong desire for pregnancy is feasible.


Asunto(s)
Anticonceptivos Femeninos , Hiperplasia Endometrial , Neoplasias Endometriales , Dispositivos Intrauterinos Medicados , Embarazo , Humanos , Femenino , Hiperplasia Endometrial/tratamiento farmacológico , Hiperplasia Endometrial/patología , Levonorgestrel/uso terapéutico , Tratamiento Conservador , Histeroscopía , Neoplasias Endometriales/terapia , Neoplasias Endometriales/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA